Nerves mount over StanChart regulatory capital deal
 

Nerves mount over StanChart regulatory capital deal
NEW YORK, Aug 17 (IFR) - Standard Chartered may have completed its latest regulatory capital relief deal - a US$165m four-year synthetic securitisation of credit risk tied to a portfolio of trade finance receivables - in the nick of time. Although it yields a hefty 9.28%, the deal is heavily reliant on Chinese commodity demand and investors may be getting nervous after the People's Bank of China devalued the renminbi last week.
http://i2.wp.com/reuters.us.feedspor...f?resize=1%2C1http://feeds.feedburner.com/~ff/reut...?d=yIl2AUoC8zA http://feeds.feedburner.com/~ff/reut...nA:V_sGLiPBpWU http://feeds.feedburner.com/~ff/reut...nA:F7zBnMyn0Lo
http://feeds.feedburner.com/~r/reute...~4/G9hk9FMlGMg